Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja XL Axiata Tbk. (EXCL) vs Tempo Scan Pacific Tbk. (TSPC)

XL Axiata Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan XL Axiata Tbk. dan Tempo Scan Pacific Tbk.: XL Axiata Tbk. diperdagangkan di Rp2.550 (kapitalisasi pasar 46,05 T, volume 24 jam 3,6 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: XL Axiata Tbk. jauh lebih besar — sekitar 4,1× kapitalisasi pasar Tempo Scan Pacific Tbk., dan XL Axiata Tbk. lebih aktif diperdagangkan (3,6 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.

EXCLTSPC
Kapitalisasi Pasar
46,05 T11,18 T
Volume
3,6 jt613 rb
Lot
35,96 rb6,13 rb
Perputaran
9,04 M1,54 M
Harga Rata-rata
2.513,72.511,52
Nilai Transaksi
9,04 M1,54 M
Harga Ekuilibrium Indikatif
2.5502.520
Volume Ekuilibrium Indikatif
97717

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EXCL
Lihat detail
TSPC
Lihat detail

Tentang XL Axiata Tbk.

PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.

Selengkapnya di halaman EXCL

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC